News | March 28, 2022
Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
The new glass-free detector has improved durability, is more reliable, and has an improved rugged design to sustain in a high workload environment
The company is Series A funded with US $ 7 million in funding so far
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Subscribe To Our Newsletter & Stay Updated
